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Background: Diabetic patients represent a frequently encountered diagnostic challenge because of atypical symptoms and more diffuse disease. 
Studies comparing PET and SPECT MPI accuracy are available only in a general population. This study was designed to compare the diagnostic 
performance of pharmacologic stress SPECT and PET in diabetic patients.
Methods: We analyzed 118 patients who underwent pharmacologic attenuation corrected SPECT MPI and 90 patients who underwent pharmacologic 
PET MPI based upon clinical referral followed by cardiac catheterization within 180 days. Images were visually interpreted using the standard 17-segment 
ASNC model. Summed stress and difference scores (SSS and SDS) were calculated. Excluded were known coronary artery disease (CAD) patients. Low-
likelihood patients were identified from the database to calculate normalcy rates
Results: Mean BMI, gender, and mean age were not significantly different in both groups. Mean SSS for PET and SPECT were10.2 and 6.6 (P<.003) 
and Mean SDS were 8.1 and 4.5 respectively (P<0.000). Sensitivity of PET and SPECT for angiographic stenosis of >70% was 93.2% and 80.8 % (p 
0.025) and for multi-vessel disease was 73.7% and 50.0% (p 0.012) respectively. Normalcy rates for PET and SPECT MPI patients were 87.5% and 
86.5% respectively. 
Conclusions: In diabetic patients, PET diagnostic accuracy is significantly higher than SPECT for CAD including multi vessel state. Cardiac PET 
should be considered as first test of choice in patients with diabetes. 
